NCCN Cancer Experts Answer Questions About COVID-19 Vaccines NCCN has published new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new 4-page patient guide is based on the
Search Results
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Alberto Delgado-Iribarren Garcia-Campero, Elvira Baos Muñoz, Sara Gil Useros, and Pedro Perez Segura
vaccine dose. Antibody titers were measured using the SARS-CoV-2 IgG II Quant assay. There was no possibility of collecting the samples within a prespecified window due to the strict COVID-19 restrictions which prevented the patients from attending to
Amye Tevaarwerk, Travis Osterman, Waddah Arafat, Jeffrey Smerage, Fernanda C.G. Polubriaginof, Tricia Heinrichs, Jessica Sugalski, and Daniel Martin
Introduction: The use of telemedicine in the oncology (Onc) setting expanded after March 2020 due to the COVID-19 pandemic. Patients and providers report satisfaction with telemedicine within the context of acute pandemic needs (Darcourt et al, JOP
William Alex Carson, Delecia Robinson, Lisa Scott, Tracie Lewis, Becky Eaddy, Annie Thibault, and Frank Berger
The COVID-19 shutdown halted elective procedures and limited in-person meetings, causing the Colorectal Cancer Prevention Network (CCPN) screening program to cease for 3 months. During this time, the CCPN focused on developing virtual patient
Updated Guidance for COVID-19 Vaccination From NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People On April 27th, 2022, NCCN released the latest recommendations from the NCCN Advisory Committee on COVID-19
Protecting People With Cancer From COVID-19: New Recommendations From Cancer Guidelines Organization On January 4, 2022, NCCN published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of
Margaret Tempero
Editor's Note: This editorial was written before the emergence of the omicron variant of COVID-19. Welcome to 2022! By the time you read this, you have probably already put away all those holiday decorations, sworn off overeating, and promised
Presenters: James E. Bachman, Kim Slusser, Thomas K. Varghese, Andrew Wagner, and moderated by Timothy Kubal
COVID-19 and Decreases in Cancer Screening As a panel of experts at the NCCN 2021 Virtual Annual Conference explained, hospitals in the Northeast, including Dana-Farber Cancer Institute and Yale Smilow Cancer Hospital, experienced a surge in
Nathan R. Handley, Justin E. Bekelman, and Adam F. Binder
As oncologists in the era of coronavirus disease 2019 (COVID-19), we are tasked with caring for patients who are at high risk for adverse effects from the novel coronavirus (SARS-CoV-2). 1 Patients with cancer face fear and anxiety related to their
Presenter: Maria Alma Rodriguez
and complete version of these NCCN Guidelines, go to NCCN.org . Current Topic of Interest: Vaccination Against Respiratory Infection Before the COVID-19 pandemic, the influenza virus was a leading concern due to its role in the development of
